Keiji Hemmi

707 citations
32 papers · 572 indexed · h-index 12
Topics
Antimicrobial Peptides and Activities (6 papers)Chemical Synthesis and Analysis (5 papers)Peptidase Inhibition and Analysis (5 papers)
Partner nations
JapanUnited KingdomIndia

In The Last Decade

Keiji Hemmi

31 papers receiving 529 citations

Peers

Keiji Hemmi
Comparison fields: 5 of 73
  • Molecular Biology 299
  • Organic Chemistry 249
  • Oncology 82
  • Cancer Research 74
  • Pharmacology 63
Replace John E. Toth with:
John E. Toth United States
Joanne M. Smallheer United States
Makoto Yoshihama Japan
Dale A. Stringfellow United States
Henry W. Dion United States
Stephan K. Grant United States
James H. Williams Australia
George W. Chan United States
Manfred Gerken Germany
Dirk A. Heerding United States
Keiji Hemmi relative to John E. Toth United States John E. Toth's profile →
Citations per field
00.5×1.5×
John E. Toth · 1×
Citations per year

Countries citing papers authored by Keiji Hemmi

Since Specialization
Citations

This map shows the geographic impact of Keiji Hemmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Hemmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Hemmi more than expected).

Fields of papers citing papers by Keiji Hemmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiji Hemmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Hemmi. The network helps show where Keiji Hemmi may publish in the future.

Co-authorship network of co-authors of Keiji Hemmi

This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Hemmi. A scholar is included among the top collaborators of Keiji Hemmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Hemmi. Keiji Hemmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 9
4 2
5 7
6 12
7 19
8 199
9 7
10 6
11 2
12 4
13 46
14 1
15 13
16 5
17 30
18 9
19 41
20 2

About Keiji Hemmi

Keiji Hemmi is a scholar working on Microbiology, Microbiology and Toxicology, having authored 32 papers that have together received 572 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (6 papers), Chemical Synthesis and Analysis (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Organic Chemistry (249 citations), Cancer Research (74 citations) and Microbiology (30 citations). Keiji Hemmi has collaborated with scholars based in Japan, United Kingdom and India. Frequent co-authors include J. Wade Harper, James C. Powers, Masashi Hashimoto, H. TAKENO, Takashi Kamiya, Ichiro Shima, Satoshi Okada, Yoshihiko Kitaura, Keisuke Imai and M. ARATANI. Their work appears in journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026